Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and epiglucan

levofloxacin has been researched along with epiglucan in 3 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(epiglucan)		Trials
(epiglucan)		Recent Studies (post-2010) (epiglucan)
4,3465812,2095,0662413,169

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazzi, W; Hadi, U; Kissoyan, KA; Matar, GM1
Chan, MY; Huang, CY; Hung, WC; Lin, L; Lin, YS; Lu, PL; Sheu, JH; Tseng, SP1
Doble, M; T S, SK; Yunus Basha, R1

Other Studies

3 other study(ies) available for levofloxacin and epiglucan

ArticleYear
The inhibition of Pseudomonas aeruginosa biofilm formation by micafungin and the enhancement of antimicrobial agent effectiveness in BALB/c mice.
    Biofouling, 2016, Volume: 32, Issue:7

    Topics: Animals; Anti-Bacterial Agents; beta-Glucans; Biofilms; Candida albicans; Drug Therapy, Combination; Echinocandins; Levofloxacin; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred BALB C; Pseudomonas aeruginosa; Pseudomonas Infections; Survival Analysis

2016
5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.
    Marine drugs, 2016, Jul-29, Volume: 14, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anthozoa; Anti-Bacterial Agents; beta-Glucans; Biofilms; Biological Products; Cross Infection; Diterpenes; Drug Resistance, Multiple, Bacterial; Drug Synergism; Equipment Contamination; Extracellular Matrix; Genes, Bacterial; Humans; Levofloxacin; Microscopy, Electron, Scanning

2016
Dual delivery of tuberculosis drugs via cyclodextrin conjugated curdlan nanoparticles to infected macrophages.
    Carbohydrate polymers, 2019, Aug-15, Volume: 218

    Topics: Animals; Antitubercular Agents; beta-Cyclodextrins; beta-Glucans; Cell Line; Drug Carriers; Drug Liberation; Levofloxacin; Macrophages; Mice; Microbial Sensitivity Tests; Mycobacterium smegmatis; Nanoparticles; Rifampin

2019